Home Healthcare Medical Devices Middle East and Africa Breast Lesion Localization Methods Market

Middle East and Africa Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire localization, Radioisotope localization, Magnetic Localization, Others), By Usage (Tumor Identification, Sentinel Lymph Node Identification) and By Country (UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, The rest of MEA) Forecasts, 2026-2034

Last Updated: September 21, 2026 | Author: Debashree Bora | Format:

Market Overview

The Middle East and Africa breast lesion localization methods market size was valued at USD 50.00 million in 2025 and is projected to grow from USD 52.70 million in 2026 to  USD 80.27 million by 2034 at a CAGR of 5.4% during the forecast period 2026-2034.

The acceptance and usage of breast lesion localization methods, including MRI, ultrasound, and mammography, are contingent upon the healthcare infrastructure of the specific healthcare systems.

Middle East and Africa Breast Lesion Localization Methods Market Size

Download a Free Sample To learn more about this report.

Segmental Analysis

The market of the Middle East and Africa breast lesion localization methods is segmented into type and usage.

By Type it is further segmented into wire localization, radioisotope localization, magnetic localization, and others.

Wire localization dominated the market and is expected to register a CAGR of 15.2% over the forecast period. Wire localization is used to designate the precise location of the lesion, which assists the surgeon in detecting and removing breast lesions if an X-ray reveals multiple lesions. The technique is favored for removing lesions or tumors that are difficult to locate and cannot be felt. In addition, it can be used to remove the smallest possible area, which would be difficult for a surgeon to do without causing obvious harm to the surrounding tissue. The procedure is painless, but some women may experience pressure or vertigo.

Middle East and Africa Breast Lesion Localization Methods Market Size By Segments

Request Customizationto receive a tailored report.

It is further segmented based on usage into tumor identification and sentinel lymph node identification.

Tumor identification dominated the market and is expected to register a CAGR of 14.4% over the forecast period. A physical examination, or breast imaging, which primarily consists of mammography and a biopsy, is performed to identify tumors. It is commonly performed on women with breast cancer. Mammography utilizes X-rays to image the breast region containing a tumor. In addition, various imaging technologies, such as MRI and ultrasound, are also utilized. Ultrasound is primarily recommended for women under the age of 30.

Middle East and Africa Breast Lesion Localization Methods Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The Middle East and Africa present a significant market for breast lesion localization methods. The rising incidence of breast cancer and increasing awareness about early detection and diagnosis drive market growth. However, limited healthcare infrastructure and access to advanced technologies pose challenges. Collaborations and partnerships with international companies are being explored to enhance regional healthcare services.

Several countries in the Middle East have robust industries, including Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, and Bahrain. In these nations, the healthcare system is highly developed. Additionally, most patients who reside here have a high per capita income. For this reason, they prefer the most effective treatment and the most advanced cancer detection technology. According to our findings, money is not a significant constraint in the Gulf States. On the other hand, African nations struggle to provide their citizens with essential healthcare.

List of Key and Emerging Players in Middle East and Africa Breast Lesion Localization Methods Market

Hologic Inc.
Mermaid Medical A/S
IZI Medical Products
Mahtek Medicals
BPP Medica
Molli Surgical
Argon Medical Devices
D.
Cianna Medical

Key Industry Developments

June 2026
Hologic expanded the regional availability of its LOCalizer wire-free breast lesion localization system through new distribution partnerships across the Middle East, supporting minimally invasive breast-conserving surgery.
April 2026
MOLLI Surgical strengthened its international commercialization strategy by expanding distribution of its wire-free breast lesion localization technology to healthcare providers in the Middle East and Africa.
February 2026
Merit Medical expanded access to its SCOUT Radar Localization System through regional channel partners, supporting improved breast lesion localization procedures across selected Middle Eastern markets.
October 2025
BD expanded its breast intervention portfolio across the Middle East and Africa with enhanced localization and biopsy solutions for breast cancer diagnosis and surgery.
July 2025
Hologic strengthened physician education and clinical training programs across the Middle East to accelerate adoption of wire-free breast lesion localization technologies.

Report Scope

Segmentation

By Type 4
  • Wire localization
  • Radioisotope localization
  • Magnetic Localization
  • Others
By Usage 2
  • Tumor Identification
  • Sentinel Lymph Node Identification
Competitive Coverage Hologic Inc. · Mermaid Medical A/S · IZI Medical Products · Mahtek Medicals · BPP Medica
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The middle east and africa breast lesion localization methods market was valued at USD 52.70 million in 2026.

Surging occurrence of breast cancer is the key driver for the growth of this market.

The key players in this market are The Hologic Inc.,Mermaid Medical A/S,IZI Medical Products,Mahtek Medicals,BPP Medica,Molli Surgical,Argon Medical Devices,D.,Cianna Medical.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: